BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32128089)

  • 21. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
    Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
    Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
    Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis.
    Shayesteh S; Guillemin GJ; Rashidian A; Faghir-Ghanesefat H; Mani AR; Tavangar SM; Dehpour AR
    Eur J Pharmacol; 2021 Oct; 908():174309. PubMed ID: 34252442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
    Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
    J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione Supplementation Attenuates Oxidative Stress and Improves Vascular Hyporesponsiveness in Experimental Obstructive Jaundice.
    Chen J; Wu F; Long Y; Yu W
    Oxid Med Cell Longev; 2015; 2015():486148. PubMed ID: 26161237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Rifaximin on Hepatic Fibrosis in Bile Duct-ligated Rat Model.
    Shin SK; Kwon OS; Lee JJ; Park YH; Choi CS; Jeong SH; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2017 Nov; 70(5):239-246. PubMed ID: 29161793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.
    Lv X; Song JG; Li HH; Ao JP; Zhang P; Li YS; Song SL; Wang XR
    World J Gastroenterol; 2011 Dec; 17(48):5267-73. PubMed ID: 22219595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
    Gómez-Hurtado I; Zapater P; Portune K; Juanola O; Fernández-Iglesias A; González-Navajas JM; Gracia-Sancho J; Sanz Y; Francés R
    Eur J Nutr; 2019 Jun; 58(4):1647-1658. PubMed ID: 29748815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation.
    Criado M; Flores O; Ortíz MC; Hidalgo F; Rodríguez-López AM; Eleno N; Atucha NM; Sánchez-Rodríguez A; Arévalo M; Garcia-Estañ J; López-Novoa JM
    Hepatology; 1997 Aug; 26(2):268-76. PubMed ID: 9252133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
    Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
    J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats.
    Jazaeri F; Tavangar SM; Ghazi-Khansari M; Khorramizadeh MR; Mani AR; Dehpour AR
    Liver Int; 2013 Mar; 33(3):368-74. PubMed ID: 23311391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of thromboxane A2 in early BDL-induced portal hypertension.
    Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid receptors blockade modulates apoptosis in a rat model of cirrhotic cardiomyopathy.
    Abbasi A; Joharimoqaddam A; Faramarzi N; Khosravi M; Jahanzad I; Dehpour AR
    Ann Med Health Sci Res; 2014 May; 4(3):404-9. PubMed ID: 24971217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
    Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
    Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of cytokine expression in cirrhotic rats.
    Hsieh HG; Huang HC; Lee FY; Chan CY; Lee JY; Lee SD
    J Chin Med Assoc; 2011 Sep; 74(9):385-93. PubMed ID: 21962246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
    Li TH; Huang CC; Yang YY; Lee KC; Hsieh SL; Hsieh YC; Alan L; Lin HC; Lee SD; Tsai CY
    PLoS One; 2016; 11(1):e0147212. PubMed ID: 26820153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.
    Cindoruk M; Kerem M; Karakan T; Salman B; Akin O; Alper M; Erdem O; Unal S
    BMC Gastroenterol; 2007 Nov; 7():44. PubMed ID: 18045488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.